Back to 
BRANDES INVESTMENT PARTNERS, LP
BRANDES INVESTMENT PARTNERS, LP
EGRXShowing 0 of 21 quarters
Position history for BRANDES INVESTMENT PARTNERS, LP's holdings in EAGLE PHARMACEUTICALS INC
No. Brandes Investment Partners exited its EGRX (Eagle Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 745,080 shares worth $3.9M. Brandes Investment Partners already held EGRX in its Q1 2019 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EGRX: Janus Henderson Group Ltd.